David A. Cairns

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

Brian A. Walker, Eileen M. Boyle, Christopher P. Wardell et al. · Journal of Clinical Oncology · 2015 · 557 citations · Full text

Second Revision of the International Staging System (R2-ISS) for Overall Survival in Multiple Myeloma: A European Myeloma Network (EMN) Report Within the HARMONY Project

Mattia D’Agostino, David A. Cairns, Juan José Lahuerta et al. · Journal of Clinical Oncology · 2022 · 371 citations · Full text

Lenalidomide maintenance versus observation for patients with newly diagnosed multiple myeloma (Myeloma XI): a multicentre, open-label, randomised, phase 3 trial

Graham Jackson, Faith E. Davies, Charlotte Pawlyn et al. · The Lancet Oncology · 2018 · 332 citations · Full text

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

Brian A. Walker, Christopher P. Wardell, Alex Murison et al. · Nature Communications · 2015 · 309 citations · Full text

Effect of Care Guided by Cardiovascular Magnetic Resonance, Myocardial Perfusion Scintigraphy, or NICE Guidelines on Subsequent Unnecessary Angiography Rates

John P. Greenwood, David P Ripley, Colin Berry et al. · JAMA · 2016 · 279 citations · Full text